Trial intelligence / Profile preview

Effect of Neonatal Procedures on aEEG in Preterms

NCT00722033Phase 2Unknown

Sponsor
Pontificia Universidad Católica de Chile
Start
Aug 2008
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of indomethacin in patent ductus arteriosus (PDA), sponsored by Pontificia Universidad Católica de Chile. Primary endpoint: aEEG voltage amplitude changes after procedures. Status: unknown.

02

Drugs

indomethacin
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on NCT00722033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00722033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call